Serotype-specific immunity and association with pneumococcal carriage following 3+1, 3+0 and 2+1 schedules of 10-valent pneumococcal conjugate vaccine

Ong et al. (Tue,) studied this question.

www.synapsesocial.com/papers/69b606ea83145bc643d1d6ea — DOI: https://doi.org/10.1093/infdis/jiag157

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Re-evaluating the impact and cost-effectiveness of pneumococcal conjugate vaccine introduction in 112 low-income and middle-income countries in children younger than 5 years: a modelling study· 2024 · 24 citations
2. Memory B cell responses induced by pneumococcal conjugate vaccine schedules with fewer doses: analysis of a randomised-controlled trial in Viet Nam· 2024 · 6 citations
3. Efficacy against pneumococcal carriage and the immunogenicity of reduced-dose (0 + 1 and 1 + 1) PCV10 and PCV13 schedules in Ho Chi Minh City, Viet Nam: a parallel, single-blind, randomised controlled trial· 2023 · 25 citations
4. Essential criteria for evaluation of pneumococcal conjugate vaccine candidates· 2009 · 22 citations
5. Are Anticapsular Antibodies the Primary Mechanism of Protection against Invasive Pneumococcal Disease?· 2005 · 134 citations